Avigen Inc (NASDAQ: AVGN) has sent a letter sent to its stockholders saying that Glass Lewis, a «leading independent voting advisory service» has reviewed the Biotechnology Value Fund (BVF) proposal to remove AVGN's board and has recommended that
stockholders vote against the proposal.
Not exact matches
The Board recommends a
vote AGAINST a
stockholder proposal seeking to have us adopt a policy requiring that senior executives retain a significant percentage of stock acquired through equity pay programs until reaching retirement age because our existing stock ownership guidelines and other compensation policies already effectively facilitate significant stock ownership by our executives, and establishing holding requirements based on a particular retirement age would not be in the best interests of our
stockholders.
Leading independent advisory service is recommending
stockholders vote AGAINST BVF's Board removal
proposal
This means that BVF's enemy is likely not
stockholders voting against BVF's
proposal, but
stockholders not
voting at all, because failing to
vote has the same effect as
voting against BVF.
The Board believes BVF would not be an appropriate steward for all
stockholders, and urges
stockholders to reject the BVF
proposal by
voting on the WHITE proxy card
AGAINST the removal of your Board.
We encourage
stockholders to support this effort and
vote AGAINST the BVF
proposal on the WHITE proxy card today.
More importantly, they will be
voting against Mr. Brewer as a director on the board in next year's proxy, and indicated they may submit «other possible related
proposals to present to the
stockholders.»
If a merger or acquisition of another company or asset were put to a
stockholder vote, we would
vote against such a
proposal and believe that other
stockholders would likely prefer to have their capital returned to them.